Webinar-
Webinar-
March 17, 2016 – 12 noon-1:00pm
Agents for Oral anticoagulant reversal: The Present and future
- · Describe the current recommendations for reversing anticoagulant effects of vitamin K antagonists, direct thrombin inhibitors, and factor Xa inhibitors.
- · Describe the indications for 4-factor prothrombin complex regarding anticoagulant reversal.
- · Discuss the mechanism of action and clinical uses of idarucizumab and andexanet alfa.
|
Georgia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1 hour (0.1 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. UAN # 0228-0000-16-011-L01-P
There is no charge for members to attend. Non-members will be charged $20.